AIM RULE 26
The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.
Plant Health Care is a leading provider of proprietary agricultural biological products and technology solutions focused on improving crop performance.
We sell products today through our Commercial segment and also invest in R&D to invent new platforms in our New Technology segment.
The mission of Plant Health Care is to provide novel naturally based products to the global agriculture industry to help feed the world.
Information updated: 29 December 2023.
| Registered name: | Plant Health Care PLC |
| Registered number: | 05116780 |
| Place of incorporation: | England |
| Registered office: | c/o DWF LLP, 1 Scott Place 2 Hardman Street Manchester M3 3AA |
| Legal form of company: | Public Limited Company |
| ISIN: | GB00B01JC540 |
| SEDOL: | B01JC54 |
| LEI: | 213800KBQPJZ2FM8QH27 |
The Company’s main country of operation is the United States of America.
Visit our Reports and presentations page for our archive of reports and documentation:
For Regulatory News Service (RNS) announcements, please view our Company news archive.
Constitutional documents
Read biographies of our Board of Directors or view our Corporate Governance and committee documentation.
Details of our NOMAD, advisers and contacts can be found within our Shareholder information section.
Or you can contact our investor relations team on ir@planthealthcare.com
There are no restrictions on the transfer of the Company’s shares.
Below are details of the number of securities in issue, the number of securities held as treasury shares and, insofar as the Company is aware, the percentage of securities that is not in public hands, together with the identity and percentage holdings of significant shareholders.
Data correct as at 31 May 2024
The number of shares in issue – 341,532,952
The number of securities held as treasury shares – NIL
Percentage of shares not in public hands – 42.16% of the Company’s securities were not in public hands.
Significant shareholders
Data correct as of 31 May 2024 – being latest share analysis date except where TR-1 notification are made subsequent to that date.
The Directors are aware of the following persons who, directly or indirectly, are invested in 3% or more of the Company’s existing ordinary share capital:
| Name | Shares held | Percentage of issued share capital* |
|---|---|---|
| Ospraie AG Science | 58,072,790 | 17.0 |
| Scobie Ward | 44,664,624 | 13.1 |
| Janus Henderson Investors Ltd. | 33,322,327 | 9.8 |
| Newlands, D. | 20,491,810 | 6.0 |
| Michael Hennigan | 19,031,106 | 5.6 |
| Boulder River Capital Corp. | 14,059,203 | 4.1 |
| Hargreaves Lansdown Stockbrokers | 13,696,298 | 4.0 |
| Lombard Odier Asset Management | 13,086,847 | 3.8 |
| Premier Fund Managers Limited | 11,983,424 | 3.5 |
| Griffiths, R. | 10,931,370 | 3.2 |
| Charles Stanley & Co. | 10,439,738 | 3.1 |
* The percentages shown are based on the most recent share register analysis or notification.
The Company is subject to the UK City Code on Takeovers and Mergers.
